Actual Medicinal Product (AMP) Lisinopril 5mg tablets (Teva UK Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Moisture sensitive medicine. Store in airtight (sealed) MCA. Original packaging may contain desiccant. No stability data in MCAs available. Anecdotal reports of use in MCAs (low quality evidence).
- Provenance
-
This recommendation is based on the products Zestril 5mg tablets (Atnahs Pharma UK Ltd) and lisinopril 5mg tablets (Viatris).
- Generic
- Lisinopril
- Formulation
- Lisinopril 5mg tablets
-
Lisinopril
-
Lisinopril 5mg tablets
-
Lisinopril 5mg tablets (Teva UK Ltd)
-
-